Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Molecules and Cells|August 30, 2018
RNA-Binding Proteins in Amyotrophic Lateral SclerosisMelody Zhao, Jihye Rachel Kim, Rebekah van Bruggen, et al.Targeted Oncology|April 19, 2023
Place in Therapy of Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: A Targeted Literature ReviewMelody Zhao, Kent A Hanson, Yixie Zhang, et al.Journal of Comparative Effectiveness Research|October 22, 2020
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysisImtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.Journal of Comparative Effectiveness Research|February 23, 2021
Efficacy classification of modern therapies in multiple sclerosisImtiaz A Samjoo, Evelyn Worthington, Christopher Drudge, et al.Multiple Sclerosis and Related Disorders|July 16, 2022
Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosisImtiaz A Samjoo, Luisa Klotz, Gavin Giovannoni, et al.Cell Reports|October 13, 2016
MECP2 Is Post-transcriptionally Regulated during Human Neurodevelopment by Combinatorial Action of RNA-Binding Proteins and miRNAsDeivid C Rodrigues, Dae-Sung Kim, Guang Yang, et al.Nature Communications|October 21, 2020
Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALSChing Serena Kao, Rebekah van Bruggen, Jihye Rachel Kim, et al.Nature Neuroscience|March 27, 2019
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neuronsKirill Zaslavsky, Wen-Bo Zhang, Fraser P McCready, et al.FEBS Letters|June 10, 2020
Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in DrosophilaMelody Zhao, Ching Serena Kao, Claudia Arndt, et al.Pageof 1